Detailed information
Notice
The information is provided in the language in which it was submitted by the researcher.
- Project title:
- Nanotechnology-enabled image-guided interventions (NanoIGI) in vascular and lung diseases
- Principal investigator(s):
- Zheng, Gang; Chan, Warren C; Wilson, Brian C
- Co-investigator(s):
- Li, Ren-Ke; Yasufuku, Kazuhiro
- Supervisors:
- N/A
- Institution paid:
- University Health Network (Toronto)
- Research institution:
- University Health Network (Toronto)
- Department:
- N/A
- Program:
- Emerging Team Grant: Regenerative Medicine and Nanomedicine - LOI
- Competition (year/month):
- 200911
- Assigned peer review committee:
- Emerging Team Grant: Regenerative Medicine and Nanomedicine
- Primary institute:
- Circulatory and Respiratory Health
- Primary theme:
- Biomedical
- Term (yrs/mths):
- 0 yr 0 mth
- CIHR contribution:
- Partner Name:
- N/A
- Amount:
- N/A
- Equipment:
- N/A
- External funding partner(s):
- Partner Name:
- N/A
- Amount:
- N/A
- Equipment:
- N/A
- External applicant partner(s):
- Partner Name:
- N/A
- Amount:
- N/A
- Equipment:
- N/A
- External in-kind partner(s):
- Partner Name:
- N/A
- Amount:
- N/A
- Equipment:
- N/A
- Keywords:
- Cardiovascular Disease; Clinical Translation; Gmp; Image-Guided Intervention; Lung Cancer; Nanotechnology
- Abstract/Summary:
- The convergence of nanotechnology and medicine offers new opportunities for improved health care, in which nanotechnology-enabled diagnosis will facilitate timely clinical interventions and mitigate patient risk and disease progression, while nanotechnology-based disease targeting will lead to safer and more effective treatments with fewer side effects. The NanoIGI Project assembles a new team of leading multidisciplinary investigators and clinicians in nanomaterials, bioconjugation chemistry, imaging sciences, biomedical engineering, and clinical trials in cardiac and lung applications - to advance an innovative two-phase research program that will pursue the development of nanotechnology into commercially viable, clinical trial-ready products and effective tools with positive health impacts for all Canadians.
- Version:
- 20250311.1